Skip to main content

Table 2 Degree of overlap between the post-treatment FDG-PET derived volumes and the pre-treatment 40% and 50% of SUV max volumes

From: Challenges in using 18 F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced pancreatic cancer

 

% intersection of the following volumes

 

Pre-treatment 40% of SUVmax

Pre-treatment 50% of SUVmax

Patient

Post90%

Post80%

Post70%

Post60%

Post90%

Post80%

Post70%

Post60%

1

100.0

87.5

87.0

83.0

50.0

68.8

66.7

64.0

2

100.0

100.0

100.0

68.9

100.0

100.0

100.0

54.5

4

100.0

100.0

100.0

95.9

100.0

16.7

87.0

81.6

5

100.0

100.0

100.0

100.0

100.0

100.0

100.0

88.5

7

0.0

0.0

6.3

18.2

0.0

0.0

0.0

6.8

8

100.0

100.0

100.0

100.0

100.0

100.0

100.0

100.0

14

100.0

100.0

100.0

90.0

100.0

100.0

81.8

70.0

16

100.0

100.0

100.0

93.4

100.0

100.0

95.0

82.9

17

50.0

68.8

60.0

51.8

50.0

43.8

40.0

35.1

Mean

83.3

84.0

83.7

77.9

77.8

69.9

74.5

64.8